Page last updated: 2024-08-26

nomegestrol acetate and Hyperlipoproteinemia Type II

nomegestrol acetate has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chevallier, T; Jamin, C; Leber, C; Micheletti, MC; Zartarian, M1

Other Studies

1 other study(ies) available for nomegestrol acetate and Hyperlipoproteinemia Type II

ArticleYear
[Biological and clinical safety of nomegestrol acetate administered alone then associated in inverse sequence with transdermal 17 beta estradiol, in women at risk of dyslipoproteinemia type IIa].
    Annales d'endocrinologie, 1998, Volume: 59, Issue:5

    Topics: Administration, Cutaneous; Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Sequential; Estradiol; Female; Humans; Hyperlipoproteinemia Type II; Megestrol; Middle Aged; Norpregnadienes; Progesterone Congeners

1998